Guidelines on Good Manufacturing Practices for Cosmetics in China

To Standardize product licensing and supervision for cosmetics, China’s National Medical Products Administration(NMPA) released the Guidelines on Good Manufacturing Practices for Cosmetics pursuant to the Regulations on the Supervision and Administration of Cosmetics and the Measures for the Supervision and Administration of Production and Distribution of Cosmetics. This provides guidance for notification persons, registration persons, and entrusted manufacturing on implementing the Good Manufacturing Practices for Cosmetics. The guidelines will come into force on 1 December 2022. The followings are specific requirements. 

1. Drug control authorities shall conduct inspections conforming to the Good Manufacturing Practices for Cosmetics and the Guidelines on Good Manufacturing Practices for Cosmetics and make comprehensive evaluations accordingly. 

 

2. For enterprises evaluated as ‘having defects in their manufacturing system’, drug control authorities shall urge them to address issues within a fixed time and submit reports. Re-inspection shall be carried out on-site if necessary. Where those, of minor violations without causing harmful consequences, comply with the Good Manufacturing Practices for Cosmetics after rectification, no administrative penalty shall be imposed on them. 

 

3. For enterprises evaluated as ‘having serious defects in manufacturing system’, drug control authorities shall promptly control risk and take emergency control measures such as ordering the suspension of production and distribution under Article 54 in the Regulations on the Supervision and Administration of Cosmetics. These enterprises shall address issues within a fixed time and submit reports to drug control authorities.  Re-inspection shall be carried out on-site. Permission for production and distribution shall be given if all regulations are complied with after the rectification. 

 

4. For enterprises evaluated as ‘having serious defects in manufacturing system’, an investigation shall be filed by drug control authorities under Item 3 of Article 60 in the Regulations on the Supervision and Administration of Cosmetics, and Article 59 of the Good Manufacturing Practices for Cosmetics, etc.